Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia.
Xu BY, Jin K, Wu HS, Liu XJ, Wang XJ, Sang H, Li KQ, Sun MJ, Meng HQ, Deng HL, Xun ZY, Yang XD, Zhang L, Li GJ, Zhang RL, Cai DF, Liu JH, Zhao GJ, Liu LF, Wang G, Zhao CL, Guo B, Jin SC, Huang LY, Yang FD, Zheng JM, Zhan GL, Fang MS, Meng XJ, Zhang GY, Li HM, Liu XL, Li JH, Wu B, Li HY, Chen JD. Xu BY, et al. Among authors: wang g, wang xj. World J Psychiatry. 2024 Nov 19;14(11):1735-1745. doi: 10.5498/wjp.v14.i11.1735. eCollection 2024 Nov 19. World J Psychiatry. 2024. PMID: 39564169 Free PMC article.
Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance.
Wu H, Wang X, Liu X, Sang H, Bo Q, Yang X, Xun Z, Li K, Zhang R, Sun M, Cai D, Deng H, Zhao G, Li J, Liu X, Zhan G, Chen J. Wu H, et al. Front Psychiatry. 2022 Aug 18;13:935769. doi: 10.3389/fpsyt.2022.935769. eCollection 2022. Front Psychiatry. 2022. PMID: 36061293 Free PMC article.
Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland China.
Yang Y, Ge H, Wang X, Liu X, Li K, Wang G, Yang X, Deng H, Sun M, Zhang R, Chen J, Cai D, Sang H, Liu X, Zhan G, Zhao G, Li H, Xun Z. Yang Y, et al. Ann Gen Psychiatry. 2023 Oct 6;22(1):37. doi: 10.1186/s12991-023-00467-w. Ann Gen Psychiatry. 2023. PMID: 37803378 Free PMC article.
The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.
Liang Y, Cao C, Zhu C, Wang C, Zhang C, Dong F, Yang F, Deng H, Yu J, Tang J, Su L, Xin L, Hong L, Gao M, Tang M, Xie S, Lu S, Liu T, Xu X, Wang X, Li X, Wang X, Li Y, Zhang Y, Chen Z, Yu X. Liang Y, et al. Asia Pac Psychiatry. 2016 Sep;8(3):241-4. doi: 10.1111/appy.12238. Epub 2016 Mar 28. Asia Pac Psychiatry. 2016. PMID: 27020720 Free PMC article. Clinical Trial.
Selective disrupted gray matter volume covariance of amygdala subregions in schizophrenia.
Chang Z, Liu L, Lin L, Wang G, Zhang C, Tian H, Liu W, Wang L, Zhang B, Ren J, Zhang Y, Xie Y, Du X, Wei X, Wei L, Luo Y, Dong H, Li X, Zhao Z, Liang M, Zhang C, Wang X, Yu C, Qin W, Liu H. Chang Z, et al. Front Psychiatry. 2024 Apr 29;15:1349989. doi: 10.3389/fpsyt.2024.1349989. eCollection 2024. Front Psychiatry. 2024. PMID: 38742128 Free PMC article.
3,428 results